Abstract
Anti-Gal is the most abundant antibody found in humans. It constitutes 1 % of circulating antibodies and interacts specifically with the α-gal epitope (Galα1-3Galβl-4GlcNAc-R). This chapter describes the studies which have red to the identification of the unique specificity of this antibody, the mechanisms inducing production of this antibody and regulating its affinity, the genes encoding this antibody, and the effects of immune tolerance on anti-Gal specificity. Understanding the various aspects of anti-Gal activity in humans and in mice that lack α-gal epitopes (i.e. knock-out mice for α-galactosyltransferase) provides paradigms for a general understanding of anti-carbohydrate immune response.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Almeida, I.C., Milani, S.R., Gorin, A.J., and Travassos, L.R., 1991, Complement mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-α-galactosyl antibodies. J. Immunol. 146:2394–2401.
Arumugham, R.G., Hsieh, T.C.Y., Tanzer, M.L., and Laine, R.A., 1986, Structures of the asparagine-linked sugar chains of laminin. Biochem. Biophys. Acta 883:112–126.
Björndal, H., Lindberg, B., and Nimmich, W., 1971, Structural studies on Klebsiella O group 1 and 6 lipopolysaccharides. Acta Chem. Scand. 25:750–762.
Buehler, J., Galili, U., and Macher, B.A., 1987, Use of enzyme-linked immunoadsorbent assay to monitor the purification of glycosphingolipid antigens by high-performance liquid chromatogrα-phy. Anal. Biochem. 164:521–525.
Castronovo, V., Parent, B., Steeg, P.S., Colin, C., Foidart, J.M., Lambotte, R., and Mahieu, P., 1989, Human natural anti-Gal antibodies may play a role in the natural anti-tumor defense system. J. Natl. Cancer lust. 81:212–216.
Curval, M., Linberg, B., Löngren, J., Ruden, U., and Nimmich, W., 1973, Structural studies on the Klebsiella O group 8 lipopolysaccharides. Acta Chem. Scand. 27:4019–4028.
Davin. J.C., Malaise, M., Foidart, J.M., and Mahieu, P., 1987, Anti-α-galactosyl antibodies and immune complexes in children with Henoch-Schönlein purpura of lgA nephropathy. Kidney Int. 31:1132–1139.
Eto, T., Iichikawa, Y., Nishimura, K., Ando, S., and Yamakawa, T., 1968, Chemistry of lipids of the posthemolytic residue or stroma of erythrocytes. XVI. Occurance of ceramide pentasaccharide in the membrane of erythrocytes and reticulocytes in rabbit.J. Biochem. (Tokyo) 64:205–213.
Gabrielli, A., Candel, M., Ricciatti, A.M., Caniglia. M.L., and Wieslander, J., 1991, Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactose (α1,3)-galactose epitopes. Clin. Exp. Immunol. 86:367–373.
Gabrielli, A., Leoni, P., Danielli, G., Herrmann, K., Krieg, T., and Wieslander, J., 1991, Antibodies against galactosyl α( 1-3)galactose in connective tissue disease. Arthritis Rheum. 34:375–376.
Galili, U., 1988a, The natural anti-Gal antibody, the B-like antigen, and human red cell aging. Blood Cells 14:205–220.
Galili, U., 1988b, The two antibody specificities within human anti-blood group B antibodies. Transfusion Med. Rev. 2:112–121.
Galili, U., 1993a, Evolution and pathophysiology of the human natural anti-Gal antibody. Springer Seminars in Immunopathology 15:155–171.
Galili, U., 1993b, Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: A major obstacle for xenotransplantation in humans. Immunology Today 14:480–482.
Galili, U., Anaraki, F., Thall, A., Hill-Black, C., and Radic, M., 1993, One percent of circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood 82:2485–2493.
Galili, U., Basbaum, C., Shohet, S.B., Buehler, J., and Macher, B.A., 1987b, Identification of erythrocyte Galα1–3Gal glycosphingolipids with a mouse monoclonal antibody Gal-13. J. Biol. Chem. 262:4683–688.
Galili, U., Buehler, J., Shohet, S.B., and Macher. B.A., 1987a, The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies. J. Exp. Med. 165:693–704.
Galili, U., Clark, M.R., and Shohet, S.B., 1986b, Excessive binding of the natural anti-α-galactosyl IgG to sickle red cells may contribute to extravascular cell destruction. J. Clin. Invest. 77:27–33.
Galili, U., Clark, M.R., Shohet, S.B., Buehler, J., and Macher, B.A., 1987b, Evolutionary relationship between the anti-Gal antibody and the Galα1–3Gal epitope in primates. Proc. Natl. Acad. Sci USA)84:1369–1373.
Galili, U., Flechner, I., Kniszinski, A., Danon, D., and Rachmilewitz. E.A., 1986a, The natural anti-α-galactosyl lgG on human normal senescent red blood cells. Br. J. Haematol. 62:317–324.
Galili, U., Korkesh, A., Kahane, I., and Rachmilewitz, E.A., 1983. Demonstration of a natural anti-galactosyl IgG antibody on thalassemic red blood cells. Blood 61:1258–1264.
Galili, U. and LaTemple, D.C., 1997, The natural anti-Gal antibody as a universal augmenter of autologous vaccine immunogenicity. Immunology Today 18:281–285.
Galili, U., LaTemple, D.C., and Radic, M.Z., 1998, A sensitive assay for measuring α-gal epitope expression on cells by a monoclonal anti-Gal antibody. Transplantation 65:1129–1132.
Galili, U., LaTemple, D.C., Walgenbach, A.W., and Stone, K.R., 1997a. Porcine and bovine cartilage transplants in cynomolgus monkey: II. Changes in anti-Gal response during chronic rejection. Transplantation 63:646–651.
Galili, U., Macher, B.A., Buehler, J., and Shohet, S.B., 1985. Human natural anti-α-galactosyl IgG. II. The specific recognition of a( 1-3)-linked galactose residues. J. Exp. Med. 162:573–582.
Galili, U., Mandrell. R.E., Hamahdeh. R.M., Shohet, SB., and Griffis. J.M., 1988. Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora. Infect. Immun. 56:1730–1737.
Galili, U. and Matta, K.L., 1996, Inhibition of anti-Gal IgG binding to porcine endothelial cells by synthetic oligosaccharides. Transplantation 62:356–262.
Galili, U., Minanov, O., Michler, R.E., and Stone, K.R., 1997b, High affinity anti-Gal IgG in chronic rejection of xenografts. Xenotransplantation 4:127–131.
Galili, U., Rachmilewitz, E.A., Peleg, A., and Flechner, I., 1984, A unique natural human IgG antibody with anti-α-galactosyl specificity. J. Exp. Med. 160:1519–1531.
Galili, U., Tibell, A., Samuelsson, B., Rydberg, L., and Groth, C.G., 1995. Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters. Transplantation 59:1549–1556.
Gerwig, G.S., deWaard, P., Kamerling. J.P., Vliegenthart. J.F.G., Morgenstern, E., Lamed, R., and Bayer. E.A., 1989. Novel O-linked carbohydrate chains in the cellulase complex Cellulosome of Clostridium thermocellum. J. Biol. Chem. 264:1027–1035.
Good, A.H., Cooper, D.C.K., Malcolm, A.J., lppolito. R.M., Koren, E., Neethling, F.A., Ye, Y., Zuhdi, N., and Lamontage. L.R., 1992. Identification of carbohydrate structures which bind human anti-porcine antibodies: implication for discordant xenografting in man. Transplant. Proc. 24:559–562.
Groth, C.G., Korsgren, O., Tibell, A., Tollerman, J., Möller, E., Bolinder, J., Ostman, J., Reinholt, F.P., Hellerstrom, C., and Andersson, A., 1994. Transplantation of fetal porcine pancreas to diabetic patients: biochemical and histological evidence for graft survival. Lancet 344:1402–1404.
Guilbert, B., Dighiero. G., and Avrameas, S., 1982, Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. J Immunol. 128:2779–2790.
Hamadeh, R.M., Galili. U., Zhou, P., and Griffis, J.M., 1995, Human secretions contain IgA. IgG and IgM anti-Gal (anti-α-galactosyl) antibodies. Clin. Diagnos. Lab. Immunol. 2:125–131.
Hamadeh, R.M., Jarvis, G.A., Galili, U., Mandrell, R.E., Zhou, P., and Griffiss. J.M., 1992, Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. J. Clin. Invest. 89:1223–1235.
Jann, K., and Jann, B., 1984. Structure and biosynthesis of O-antigens. In: Riestcel, E.T. (ed). Handbook of endotoxins, vol l. Chemistry of endotoxins. Elsevier, Amsterdam, p. 138.
Jansson, P.E., Lindberg, A.A., Lindberg, B.and Wollin. R., 1981. Structural studies on the hexose region of the core lipopolysaccharides from Enterobacteriaceae. Eur. J. Biochem. 115:571–577.
Kabat, E.A., 1976, Structural concepts in immunology and immunochemistry (2nd Ed). Hold, Rinehart & Winston. New York. 174–189.
Kozlowski, T., lerino, F., Lambrigts, D., Foley, A., Andrews, D., Awwad, M., Monroy, R., Cosimi, A.B., Cooper, D.K.C., and Sachs, D.H., 1998, Depletion of anti-Galα1–3Gal antibody in baboons by specific α-gal immunoaffinity columns. Xenotransplantation 5:122–131.
Landsteiner, K., and Philip-Miller, C., 1925, Serological studies on the blood of the primates. III. Distribution of serological factors related to human isoagglutinations in the blood of lower monkeys. J. Exp. Med. 42:863–875.
LaTemple, D.C., and Galili, U., 1998, Adult and neonatal anti-Gal response in knock-out mice for α-galactosyltransferase. Xenotransplantation 1998, in press.
LaTemple, D.C., Henion, T.R., Anaraki, F., and Galili, U., 1996, Synthesis of α-galactosyl epitopes by recombinant α 1,3galactosyltransferase for opsonization of human tumor cell vaccines by anti-Gal. Cancer Research 56:3069–3074.
Lüderitz, O., Simmons, D.A.R., and Westphal, O., 1965. The immunochemistry of Salmonella chemotype VI O-antigen. The structure of oligosaccharides from Salmonella group U 043 lipopolysaccharides. Biochem. J. 97:820–832.
Lutz, H.U., Flepp, R., and Stringnaro-Wipf, G., 1984, Naturally occurring antibodies to exoplasmic and cryptic regions of band 3 protein, the major integral protein of human red blood cells. J. Immunol. 133:2610–2618.
Magnani, J.L., Brockhaus, M., Smith, D.F., Ginsburg, V., Blaszczyk, M., Mitchell, K.F., Steplewski, Z., and Koprowski, H., 1981, A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science 212:55–56.
McMorrow, I.M., Comrack, C.A., Nazarey, P.P., Sachs. D.H., and DerSimonian, H., 1997, Relationship between ABO blood group and levels of αGal 1,3galactose-reactive human immunoglobulin G. Transplantation 64:546–549.
Minanov, O.P., Itescu, S., Neethling, F.A., Morgenthau, A.S., Kwiatkowski, P., Cooper, D.K.C, and Michler, R.E., 1997, Anti-Gal IgG antibodies in sera of newborn humans and baboons and its significance in pig xenotransplantation. Transplantation 63:182–186.
Parker, W., Bruno, D., Holzknecht, Z.E., and Platt, J.L., 1994, Characterization and affinity isolation of xenoreactive human natural antibodies. J. Immunol. 153:3791–803.
Ravindran, S., Satapathy, A.K., and Das, M.K., 1988, Naturally occurring anti-α-galactosyl antibodies in human Plasmodium falciparum infections: a possible role for autoantibodies in malaria. Immunol. Lett. 19:137–142.
Sandrin, M., Vaughan, H.A., Dabkowski, P.L., and McKenzie, I.F.C., 1993, Anti-pig IgM antibodies in human serum react predominantly with Galα1–3Gal epitopes. Proc. Natl. Acad. Sci. USA 90:11391–11395.
Sandrin, M.S., Vaughan, H.A., Xing, P-X., and McKenzie, I.F.C., 1997, Natural human anti-Galα(1,3)Gal antibodies react with human mucine peptides. Glycoconjugates J. 14:97–105.
Satake, M., Kawagishi, N., Rydberg, L., Samuelsson. B.E., Tibell, A., Groth. C.G., and Möller, E., 1994, Limited specificity of xenoantibodies in diabetic patients transplanted with fetal porcine islet cell clusters. Main antibody reactivity against α-linked galactose-containing epitopes. Xenotransplantation 1:89–101.
Shibata, S., Peters, B.P., Roberts, D.D., Goldstein, T.J., and Liotta, L.A., 1982, Isolation of laminin by affinity chromatography on immobilized Griffonia simplicifolia I lectin. FEBS Lett. 142:194–197.
Shinkel, T.A., Chen, C.G., Salvaris, E., Henion, T.R., Barlow, H., Galili, U., Pearse, M.J., and d’Apice, A.J., 1997, Changes in cell surface glycosylation in α-galactosyltransferase knock-out and α1,2-fucosyltransferase transgenic mice. Transplantation 95:574–579.
Socha, W.W., and Ruffie, J., 1983, Blood groups of primates: Theory, practice, evolutionary meaning. Liss. New York, 39–51.
Spiro, R.G., and Bhoyroo, V.D., 1984, Occurance of α-D-galactosyl residues in the thyroglobulin from several species. Localization in the saccharide chains of the complex carbohydrate units. J. Biol. Chem. 259:9858–9866.
Springer, G.F., 1971, Blood-group and Forssman antigenic determinants shared between microbes and mammalian cells. Prog. Allergy 15:9–77.
Springer, G.F., and Horton, R.E., 1969. Blood group isoantibody stimulation in man by feeding blood group-active bacteria. J. Clin. Invest. 48:1280–1291.
Stellner. K., Saito. H., and Hakomori. S., 1973. Determination of aminosugar linkage in glycolipids by methylation. Aminosugar linkage of ceramide pentasaccharides of rabbit erythrocytes and of Forssman antigen. Arch. Biochem. Biophys. 133:464–472.
Stone, K.R., Ayala. G., Goldstein, J., Hurst. R., Walgenbach, A., and Galili. U., 1998. Porcine cartilage transplants in cynomolgus monkey: III. Transplantation of α-galactosidase treated porcine cartilage. Transplantation 65:1577–1583.
Stone, K.R., Walgenbach, A. W., Abrams. T., Nelson. J., Gellett. N., and Galili. U., 1997. Porcine and bovine cartilage transplants in cynomolgus monkey: 1. A model for chronic xenograft rejection. Tranplantation 63:640–645.
Suzuki, E., and Naiki, M., 1984. Heterophile antibodies to rabbit erythrocytes in human sera and identification of the antigen as a giycolipid. J. Biochem. (Tokyo) 95:103–108.
Teneberg. S., Lönnroth. 1., Torres Lopez. J.F., Galili. U., Olwegard Halvarsson. M., Angstrom. J., and Karlsson. K-A., 1996. Molecular mimicry in the recognition of glycosphingolipids by Galα3Galβ4GlcNAcβ-binding Closiridium difficile toxin A. human natural anti-α-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid. non-identical with the animal receptor. Glycobiology 6:599–609.
Thall, A.D., Maly. P., and Lowe. J.B., 1995. Oocyte Galα 1-3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J. Biol. Chem. 270:21437–21442.
Thall, A.D., Murphy. H.S., and Lowe. J.B., 1996. α-galactosyltransferase deficient mice produce naturally occurring cytotoxic anti-Gal antibodies. Transplant. Proc. 28:556–557.
Towbin, H., Rosenfelder. G., Weislander. J., Avila. J.L., Rojas, M., Szarfman, A., Esser. K., Nowack, H., and Timple. R., 1987. Circulating antibodies to mouse laminin in Chagas disease. American cutaneous Leishmaniasis and normal individuals recognize terminal galactosyl (α 1-3) galactose epitopes. J. F.xp. Med. 166:419–432.
Wang. L., Anaraki. F., Henion. T.R., and Galili. U., 1995a. Variations in activity of the human natural anti-Gal antibody in young and elderly populations. J. Gerontol. (Med. Sci.) 50A:M227–M233.
Wang, L., Radic, M.Z., and Galili. U., 1995b. Human anti-Gal heavy chain genes: Preferential use of VH3 and the presence of somatic mutations. J. Immunol. 155:1276–1285.
Watkins, W.M., 1966. Blood group substances. Science 152:172–181.
Wiener, A.S., 1951. Origin of naturally occurring hemagglutinins and hemolysins: A review. J. Immunol. 66:287–295.
Weislander, J., Mannsono, O., Kallin, E., Gabrielli, A., Nowack, H., and Timple, R., 1990, Specificity of human antibodies against Galα 1–3Gal carbohydrate epitope and distinction from natural antibodies reacting with Galαl-2Gal or Galα1–4Gal. Glycoconjugate J. 7:85–94.
Xu, Y., Lorf. T., Sablinski. T., Gianello. P., Bailin. M., Monroy. R., Kozlowski. T., Cooper. D.K.C., and Sachs, D.H., 1998. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galα 1–3Galβ 1-4Glc-R immunoaffinity column. Transplantation 65:172–179.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Galili, U., Wang, L., LaTemple, D.C., Radic, M.Z. (1999). The Natural Anti-Gal Antibody. In: Galili, U., Avila, J.L. (eds) α-Gal and Anti-Gal. Subcellular Biochemistry, vol 32. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4771-6_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4771-6_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7160-1
Online ISBN: 978-1-4615-4771-6
eBook Packages: Springer Book Archive